Abstract
It is well recognized that during atrial fibrillation (AF), clots may form in the left atrium, which may embolize and cause ischemic stroke or systemic embolism. The presence of AF confers a fivefold increased risk for stroke. AF is the most common and important cause of stroke. This article considers the risks for and anticoagulation prophylaxis against embolic stroke in patients who have AF.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Administration, Oral
-
Anti-Arrhythmia Agents / therapeutic use
-
Anticoagulants / administration & dosage
-
Anticoagulants / therapeutic use*
-
Atrial Fibrillation / complications*
-
Atrial Fibrillation / therapy
-
Electric Countershock
-
Europe
-
Humans
-
Practice Guidelines as Topic
-
Prognosis
-
Stroke / etiology
-
Stroke / prevention & control*
-
United States
Substances
-
Anti-Arrhythmia Agents
-
Anticoagulants